How many insider declarations does Glenmark Pharmaceuticals Limited have?

Glenmark Pharmaceuticals Limited has filed 13 insider declarations with SEBI (PIT + SAST).

Who is the top reporting insider at Glenmark Pharmaceuticals Limited?

The top reporting insider at Glenmark Pharmaceuticals Limited is Glenn Mario Saldanha, based on the count of public filings.

What is the net insider buy vs sell volume on Glenmark Pharmaceuticals Limited?

Across the available history, declared buys total 204k€ and disposals 28k€.

InsidersTradesSigma

← Companies ★ Sign in to follow

Glenmark Pharmaceuticals Limited: insider trades · India · SEBI (PIT + SAST)

SEBI:glenmark-pharmaceuticals-limitedIN·SEBI (PIT + SAST)Mcap 434.6Bn€

AMF ↗

Discover the full directors' dealings record of Glenmark Pharmaceuticals Limited, a listed issuer based in India. Shares are listed on IN IN, under the oversight of SEBI (PIT + SAST). Market capitalisation: €434.6bn. The latest transaction was disclosed on 22 September 2023 — Sale. Among the most active insiders: Glenn Mario Saldanha. Every trade is accessible without an account.

13

Insider Decl.

0

Thresholds

€203,926

7 ops.

Buy Volume

€27,554

6 ops.

Sell Volume

Financial data

FY ended March 2025 · cache

2339.90 €

Income statement

Revenue131.46 Bn€

Gross profit83.88 Bn€64% margin

Net income10.47 Bn€8.0% margin

Balance sheet & cash

Market cap434.58 Bn€

Total debt24.73 Bn€

Free Cash Flow−15.77 Bn€

Last declaration on 22 September 2023

All Executives13 Thresholds Prospectus Other

Declarations0 total

No declarations found

0 of 0 declarations